
Primary tabs
Export 7 results:
Filters: Author is N.M. Vandevelde
Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.,
, Orphanet J Rare Dis, 2021 Feb 17, Volume 16, Issue 1, (2021)
Frequency of Participation in External Quality Assessment Programs Focused on Rare Diseases: Belgian Guidelines for Human Genetics Centers.,
, JMIR Med Inform, 2021 Jul 12, Volume 9, Issue 7, (2021)
A pragmatic bottom-up approach to harmonize the units of clinical chemistry tests among Belgian clinical laboratories, focusing on immunoassays.,
, Clin Chem Lab Med, 2018 Dec 19, Volume 57, Issue 1, (2018)
Acceptance sampling theory applied to EQA sample homogeneity testing,
, EQALM Meeting 2015, 8/10/2015, Issue EQALM, European Organisation For External Quality Assurance Providers in Laboratory Medicine, NA, (2015)
Belgian National Plan for Rare Diseases ,
, International symposium Metabolics.be , 22/10/2015, Issue metabolics.be, (2015)
In vitro susceptibility of S. pneumoniae to solithromycin (SOL) in Belgian and German collections with an elevated percentage of isolates resistant to macrolides and fluoroquinolones.,
, 25 th European Congress of Clinical Microbiology and Infectious Diseases., 0/0/2015, Issue XX, (2015)
Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: in vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes...,
, Int.J.Antimicrob.Agents, 0/9/2014, Volume 44, Issue 3, Number 217, p.209 - 217, (2014)